Midaxo Cloud for Corporate Development Launches to Accelerate and Improve the Consistency of Inorganic Growth
First purpose-built work management solution for corporate development teams
BOSTON, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Midaxo, the leading provider of software solutions for corporate development today announced the launch of the next generation Midaxo Cloud, a purpose-built work management solution for corporate development and deal integration teams that enables them to find, evaluate, and deliver deals to drive inorganic growth faster and more efficiently than ever before. The AI-powered Midaxo Cloud leverages learnings from over 500 Midaxo customers that have completed more than 5,000 transactions worth in excess of $1 trillion.
“Corporate development teams are under pressure to consistently deliver higher inorganic growth rates. Until now, their efforts have generally been managed using Excel and legacy tools. Midaxo Cloud is the first purpose-built work management solution for the modern corporate development department,” said Midaxo CEO Jude McColgan. “When a Board or CEO says they need more inorganic growth options to grow and outcompete peers, they need a platform to support their growth via M&A and other corporate development activities. When finding, reviewing, and delivering deal value, they need the best technology available. From sourcing deal targets using AI and data intelligence, to identifying risks and timelines, to creating and managing effective workflows for integration teams to collaborate smoothly, an ideal solution is now available. The new Midaxo Cloud platform consolidates information, workflows, and reporting to support all forms of corporate development, including M&A, divestitures, asset rationalizations, and partnerships. The result is standardized and more efficient processes that reduce risk, increase inorganic growth rates, and create happier, more productive team members.”
A Modern Platform for Faster and More Consistent Inorganic Growth
Midaxo Cloud powers an enterprise-wide approach to all corporate development activities that increases team productivity and consistency, enables faster deal closings, better prepares teams for antitrust challenges, and reduces transaction risks. As the first purpose-built work management platform for corporate development, the platform delivers more repeatable business outcomes and faster inorganic growth. The key benefits of Midaxo Cloud include:
- All Information and Workflows in One Place – All documents, communications, approvals, reporting, and workflows are within the platform so team members can seamlessly collaborate on shared workflows using the same set of information. Rich native integrations with best-of-breed third-party tools make Midaxo Cloud the source of truth for all corporate development activities.
- Full Visibility – Team members can view the information they need, when they need it, whether for company-wide Board reports or to drive day-to-day activities. Role-based dashboards and reports provide the intelligence team members and management need to prioritize their work.
- Consistent Workflows – Purpose-built workflows powered by user-customizable playbooks reduce complexity and increase repeatability for every step in the transaction process.
- Tighter Collaboration – Effective information sharing and seamless access to workflows and deal information all in one place increase team member happiness and productivity. Secure online and mobile app access enables users to leverage the platform anywhere at any time.
- Painless Reporting – Informed management decisions can be powered by custom reporting using embedded analytics or they can leverage integrations with popular analytics tools such as Power BI or Tableau.
- AI and Automation – Automated data intelligence and AI help identify, prioritize, and flag opportunities. Reviews of diligence materials can be automated and projects can be more effectively managed leveraging AI and automation within the platform.
To learn more, register for the November 1, 2023 webinar 4 Ways the New Midaxo Cloud Accelerates Inorganic Growth, which will introduce the next-generation Midaxo Cloud and reveal how it can empower teams to consistently deliver higher, more predictable inorganic growth rates across all their corporate development activities.
Midaxo provides the most widely used work management solution for corporate development. Digitally transforming the transaction process, Midaxo Cloud leverages automation, AI, and machine learning to deliver accelerated inorganic growth while decreasing deal risk. The platform can be customized to fit the needs of each company to enable corporate development and M&A leaders to find, evaluate, and deliver inorganic growth with unprecedented speed and accuracy. Users of the M&A capabilities report identifying and managing 5x more targets, reducing diligence time by 50%, and accelerating time to value realization up to 40%. More than 500 Midaxo customers, including Banner Health, Daimler AG, Professional Services Co., and United Site Services, have closed over 5,000 transactions valued in excess of $1 trillion. For more information, visit Midaxo.com.
All product and company names herein may be trademarks of their registered owners.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Challenging conditions to persist, but expectation of clearer rate outlook and tightening bid-ask spreads on the horizon29.11.2023 01:00:00 CET | Press release
Industrial & logistics, multifamily, and office remain top picks for 2024 with investors deploying new strategies in each sector LONDON and TORONTO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The 2024 Global Investor Outlook released by Colliers (NASDAQ and TSX: CIGI) today reveals that challenging market conditions will persist into 2024, though expectations of a clearer rate outlook and tightening bid-ask spreads are on the horizon. Lower investment activity has constrained pricing discovery due to limited data points. As investors continue to seek stability in policy environments, industrial & logistics (I&L), multifamily and office sectors largely remain their top picks in the upcoming year. Pockets of opportunity are continuing to emerge as distress forces companies to unlock capital via sale and leasebacks, and property funds face redemption pressures. Furthermore, a record proportion (25%) of investors surveyed have ESG-based disposal and acquisition strategies in place – up from 10% jus
Nyxoah Strengthens its Executive Leadership Team28.11.2023 22:30:00 CET | Press release
Nyxoah Strengthens its Executive Leadership Team Francis Kim appointed as Chief Regulatory and Quality Officer Mont-Saint-Guibert, Belgium – November 28, 2023, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Francis Kim as Chief Regulatory and Quality Officer. Francis will be leading Nyxoah’s Global Regulatory and Quality departments. Francis is a highly experienced global regulatory and quality executive in the healthcare industry, having spent more than 25 years in the medical device and life sciences sector. Francis has led Regulatory and Quality departments at Medtronic, Philips, and other companies, including introducing several innovative products and therapies to the market. “Nyxoah is entering the most exciting time in the Company’s history, with data fro
Alvotech Reports Financial Results for First Nine Months of 2023 and Provides Business Update28.11.2023 22:15:00 CET | Press release
Product revenue for the nine months of 2023 increased to $29.8 million, compared to $11.1 million for the same period in 2022Marketing authorization was received for AVT04 in Canada and Japan, the first for a biosimilar to Stelara® (ustekinumab)The European Medicines Agency proposed market authorization for AVT04 in the 30 member states of the European Economic Area, pending a final decision by the European CommissionApprovability of AVT02 and AVT04 in the U.S. now pending satisfactory US Food and Drug Administration (FDA) inspection of Alvotech’s facility in Iceland, currently expected on January 10 – 19, 2024Management will conduct a business update conference call and live webcast on Thursday November 29, 2023, at 8:00 am ET (13:00 pm GMT) Alvotech (NASDAQ: ALVO, or the “Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today reported unaudited financial results for the first nine months of 2023 and pr
RÄTTELSE: Saknad MAR-etikett i tidigare pressmeddelande – ”Anoto ingår ett avtal för 1,1 miljoner USD avseende försäljning av pennor och treåriga mjukvarulicenser med Deutsche Telekom”28.11.2023 19:15:00 CET | Pressemelding
Anoto Group AB (publ) utfärdar en rättelse av pressmeddelandet som publicerades tidigare idag. Rättelsen avser att pressmeddelandet saknade MAR-etikett med hänvisning till EU:s marknadsmissbruksförordning (MAR). Följande information skulle ha varit med i pressmeddelandet: ”Denna information är sådan information som Anoto Group AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades genom ovanstående kontaktpersons försorg för offentliggörande den 28 november 2023, kl. 08:00 CEST.” Nedan publiceras det korrekta pressmeddelandet i sin helhet. Stockholm den 28 november 2023 – Anoto Group AB (publ) ("Anoto" eller "Bolaget") meddelar idag att bolaget har tecknat ett upphandlingsavtal som avser försäljning av nya pennor, samt ett treårigt mjukvarulicensavtal med Deutsche Telekom AG (”Deutsche Telekom”). Deutsche Telekom är en av de äldsta kunderna inom Anotos affärssegment Forms och avtalet innebär att ramverket inom vilket Anoto och Deutsche T
CORRECTION: Missing MAR label in previous press release – “Anoto enters into a USD 1.1 million agreement for the sale of pens and three-year software licenses with Deutsche Telekom”28.11.2023 19:15:00 CET | Press release
Anoto Group AB (publ) issues a correction to the press release published earlier today. The correction refers to the fact that the press release lacked a MAR label with reference to the EU Market Abuse Regulation (MAR). The following information should have been included in the press release: ”This information constitutes inside information as Anoto Group AB (publ) is obliged to disclose under the EU Market Abuse Regulation 596/2014. The information was provided by the contact person above for publication 28 November 2023, at 08:00 CEST.” The correct press release is published in its entirety below. Stockholm, 28 November 2023 – Anoto Group AB (publ) ("Anoto" or the "Company") today announces that it has signed a procurement agreement relating to the sale of new pens, plus a new three-year software licensing agreement with Deutsche Telekom AG (“Deutsche Telekom”). Deutsche Telekom is one of the oldest customers of Anoto’s Forms business and this agreement means that the framework withi